简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-05-06 10:32 A Study Showing Mounting Evidence of Harmful Effects Of WiFi Router Electromagnetic Waves on Sperm to Be Presented at ASPIRE 2019 Congress
2019-05-06 10:08 Philip Morris International CEO to Speak at Boston College Chief Executives Club
2019-05-06 09:57 MEDIKEY Blockchain Gym Makes its Debut at Las Vegas Country Club
2019-05-06 09:49 Health-Related Blockchain Leader MEDIKEY Goes Public on Bit-Z, Only a Month After It Was Listed on DIGIFINEX
2019-05-06 09:44 Philip Morris International Announces U.S. Food and Drug Administration Authorization For Sale of IQOS in the United States
2019-04-30 15:21 tHIS 2019 to Shape Future Health Science and Technology With Expanded Exhibition Scale in Shanghai and Hangzhou
2019-04-30 14:02 Masimo Announces First CE-marked Third-party Masimo Open Connect® Module for the Root® Patient Monitoring and Connectivity Hub
2019-04-29 16:34 Ashcroft Announces Acquisition of Rüeger SA and Stiko BV
2019-04-29 09:44 Celgene Corporation and Acceleron Pharma Announce Submission of Luspatercept Marketing Authorization Application to the European Medicines Agency (EMA) for MDS and Beta-Thalassemia
2019-04-25 16:12 Biomedical Software Startup BostonGene Secures $50M in Series A Financing from NEC
2019-04-25 10:18 Kao Launches New ESG Strategy “Kirei Lifestyle Plan” to Support Consumer Lifestyle Changes
2019-04-25 09:49 Aptorum Group Establishes Smart Pharma to Focus on Computational Repurposed Drug Discovery for Orphan and Unmet Diseases
2019-04-25 09:45 USD$90 Million Initiative between A*Star, Aptorum Group and Aeneas Capital to Drive Healthcare Innovations
2019-04-25 09:39 Aptorum Group’s Smart Pharma announces launch of its asset backed Smart Pharma token (SMPT), supported by its computational repurposed drug discovery platform Smart-ACT™
2019-04-24 18:46 Infraredx, a Nipro Company, Announces FDA Approval of Expanded Label Claim for the Makoto™ Intravascular Imaging System
2019-04-24 16:26 Aptorum Group Limited Announces Repurchase of USD13,500,000 Outstanding Convertible Bonds Due 2019
2019-04-23 10:12 Comprehensive Tumor Profiling Promises New Therapeutic Options for Patients with Advanced Cancer
2019-04-19 16:58 KCI Files Registration Statement for Proposed Initial Public Offering
2019-04-18 10:03 French Biotech CellVax is Now Able to Propose Preclinical Studies in Large Animals
2019-04-17 16:58 Financial year 2018: Boehringer Ingelheim grows and invests

Business Wire Weibo

Press Releases

Latest Releases